COVID-19: Roche’s Antibody Cocktail Launched In India
Roche India and Cipla on Monday announced launch of Roche's Antibody Cocktail in India priced at Rs 59750 per dose for the treatment of coronavirus.
Browsing Tag
Cipla
Cipla, Hetero get DCGI’s nod to launch Remdesivir forCovid-19 treatment
India's Drug Regulator gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir for treatment of Covid-19 Patients on Oxygen Support
Sensex Closes 145 points higher to 36,496; rupee hits a record low 69.13
On Friday, domestic stock markets moved higher which were driven by IT stocks and got a boost on the latest bout of weakness in the rupee against US dollar. The BSE benchmark index Sensex…